Photochemotherapie bei Psoriasis

: Photochemotherapy, a recently developed method of treatment, is based on the effect of light on a systemically administered photo-active substance. 152 patients with severe generalized psoriasis were exposed, after oral administration of 8-methoxy-psoralen, to a high-intensity UVA light source radiating at a continuous spectrum between 320 and 390 nm (maximum at 365 nm). Radiation doses ranged from 1.4 to 4.8 J/cm2 and were progressively increased. Complete remission occurred in 141 patients, satisfactory improvement in the remaining 11. It required 12+/-6 radiation sessions (-/x +/- s) to obtain remission, mean duration of treatment being 22 +/- 14 days. Apart from a neutral ointment no other local or systemic therapy was used. Photochemotherapy completely healed the psoriatic foci leaving evenly tanned, cosmetically appealing skin. All patients were treated at intervals as out-patients (average once a week or ev-ry other week), and remained without recurrence for up to 400 days. No local treatment is required with photochemotherapy, which is very effective, simple, harmless and does not stress patient or doctor. Interval treatment maintained the cure.

[1]  J. Parrish,et al.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. , 1974, The New England journal of medicine.

[2]  J. Voorhees,et al.  Psoriasis improved by psoralen plus black light. , 1973, Acta dermato-venereologica.

[3]  Z. Št̕áva [Methotrexate in the therapy of psoriasis]. , 1973, Ceskoslovenska dermatologie.

[4]  J. Voorhees,et al.  Psoralen plus black light inhibits epidermal DNA synthesis. , 1973, Archives of dermatology.

[5]  R. S. Cole Repair of DNA containing interstrand crosslinks in Escherichia coli: sequential excision and recombination. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Delhanty,et al.  DNA synthesis in normal and xeroderma pigmentosum fibroblasts following treatment with 8-methoxypsoralen and long wave ultraviolet light. , 1972, Biochimica et biophysica acta.

[7]  H. Dubin,et al.  Azaribine in the treatment of psoriasis. , 1971, Annals of internal medicine.

[8]  E. Epstein,et al.  Effects of topical mechlorethamine on skin lesions of psoriasis. , 1970, Archives of dermatology.

[9]  D. M. Krämer,et al.  Photosensitization of skin in vivo by furocoumarins (psoralens). , 1969, Biochimica et biophysica acta.

[10]  H. Perry,et al.  The Goeckerman treatment of psoriasis. , 1968, Archives of dermatology.

[11]  G. Weinstein,et al.  Abnormal cell proliferation in psoriasis. , 1968, The Journal of investigative dermatology.

[12]  A. Griffin,et al.  Photosensitization of the eye with methoxsalen. II. Chronic effects. , 1961, Archives of ophthalmology.

[13]  J. Knox,et al.  Erythema and tumor formation in methoxsalen-treated mice exposed to flourescent light. , 1960, Archives of dermatology.

[14]  H. A. Tucker Clinical and laboratory tolerance studies in volunteers given oral methoxsalen. , 1959, The Journal of investigative dermatology.

[15]  J. Knox,et al.  The wave length effect upon erythemal and carcinogenic response in psoralen treated mice. , 1958, The Journal of investigative dermatology.

[16]  G. Weinstein,et al.  Methotrexate for psoriasis. A new therapeutic schedule. , 1971, Archives of dermatology.

[17]  A. Griffin Methoxsalen in ultraviolet carcinogenesis in the mouse. , 1959, The Journal of investigative dermatology.